ResMed

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ResMed and other ETFs, options, and stocks.

About RMD

ResMed, Inc. engages in providing digital health and cloud-connected medical devices. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, chronic obstructive pulmonary disease, or COPD, and other chronic diseases. 

CEO
Michael J. Farrell
CEOMichael J. Farrell
Employees
10,600
Employees10,600
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
1989
Founded1989
Employees
10,600
Employees10,600

RMD Key Statistics

Market cap
37.45B
Market cap37.45B
Price-Earnings ratio
26.26
Price-Earnings ratio26.26
Dividend yield
0.88%
Dividend yield0.88%
Average volume
828.80K
Average volume828.80K
High today
$257.98
High today$257.98
Low today
$254.40
Low today$254.40
Open price
$255.35
Open price$255.35
Volume
701.37K
Volume701.37K
52 Week high
$293.81
52 Week high$293.81
52 Week low
$199.92
52 Week low$199.92

Stock Snapshot

ResMed(RMD) stock is priced at $256.55, giving the company a market capitalization of 37.45B. It carries a P/E multiple of 26.26 and pays a dividend yield of 88.1%.

On 2025-12-06, ResMed(RMD) stock traded between a low of $254.40 and a high of $257.98. Shares are currently priced at $256.55, which is +0.8% above the low and -0.6% below the high.

The ResMed(RMD)'s current trading volume is 701.37K, compared to an average daily volume of 828.8K.

During the past year, ResMed(RMD) stock moved between $199.92 at its lowest and $293.81 at its peak.

During the past year, ResMed(RMD) stock moved between $199.92 at its lowest and $293.81 at its peak.

RMD News

Simply Wall St 2d
ResMed Valuation Check After Goldman Sachs Drops Stock From APAC Conviction List

ResMed (RMD) just dropped off Goldman Sachs’ APAC Conviction List, a move that often nudges investor sentiment even if it does not change the underlying busines...

ResMed Valuation Check After Goldman Sachs Drops Stock From APAC Conviction List
TipRanks 2d
ResMed Inc Announces Changes in Beneficial Ownership

TipRanks Cyber Monday Sale Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRank...

Nasdaq 4d
Should You Continue to Hold RMD Stock in Your Portfolio?

Resmed Inc. RMD continues to see strong demand for its market-leading mask portfolio, including AirFit, AirTouch and other ranges. The company often relies on s...

Should You Continue to Hold RMD Stock in Your Portfolio?

Analyst ratings

76%

of 29 ratings
Buy
75.9%
Hold
20.7%
Sell
3.4%

More RMD News

Simply Wall St 4d
Should Goldman’s Conviction List Exit and New Stock Plans Require Action From ResMed Investors?

ResMed recently saw Richard Sulpizio step down from its board and filed two employee stock ownership-related shelf registrations totaling about US$1.32 billion...

Should Goldman’s Conviction List Exit and New Stock Plans Require Action From ResMed Investors?

People also own

Based on the portfolios of people who own RMD. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.